Real-World Budget Impact of the Adoption of Insulin Glargine Biosimilars in Primary Care in England (2015-2018).

Ion Agirrezabal Eduardo Sánchez-IrisoKiran MandarJuan M Cabases-Hita

Published in: Diabetes care (2020)

These results may encourage decision makers in England to promote the use of best-value treatments in primary care and to reevaluate variation across CCGs.

Keyphrases

primary care
type diabetes
glycemic control
general practice
electronic health record
adipose tissue
insulin resistance
weight loss